Bioptic Inc.(TW:6850)
NT$27.65-0.15 (-0.54%)
TW:6850
Bioptic Inc. financials statements
NT$27.65
At close:-0.15 (-0.54%)
Bioptic Inc. (6850) Ratios
Bioptic Inc. Ratios
TW:6850's free cash flow for Q2 2026 was NT$22.39M. For the 2026 fiscal year, TW:6850's free cash flow was decreased by NT$-591.00K and operating cash flow was NT$22.98M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.26 | 6.28 | 3.92 | 4.44 | 6.65 |
| Quick Ratio | 4.54 | 3.01 | 1.84 | 3.01 | 4.85 |
| Cash Ratio | 3.93 | 2.07 | 1.04 | 2.47 | 3.50 |
| Solvency Ratio | 0.15 | 0.30 | 0.31 | 0.76 | 1.19 |
| Operating Cash Flow Ratio | 2.07 | 0.65 | -0.16 | 0.83 | 0.76 |
| Short-Term Operating Cash Flow Coverage | 9.33 | 14.24 | -5.38 | 35.09 | 16.38 |
| Net Current Asset Value | NT$ 188.92M | NT$ 163.12M | NT$ 132.98M | NT$ 278.50M | NT$ 240.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.14 | 0.15 | 0.03 | 0.01 |
| Debt-to-Equity Ratio | 0.19 | 0.19 | 0.22 | 0.03 | 0.02 |
| Debt-to-Capital Ratio | 0.16 | 0.16 | 0.18 | 0.03 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.14 | 0.15 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.33 | 1.42 | 1.25 | 1.14 |
| Debt Service Coverage Ratio | 4.26 | 10.11 | 15.29 | 32.64 | 21.75 |
| Interest Coverage Ratio | 19.68 | 9.73 | 32.78 | 227.29 | 72.51 |
| Debt to Market Cap | 0.07 | 0.07 | 0.06 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.78 | 2.93 | 3.13 | 0.49 | 0.26 |
| Net Debt to EBITDA | -1.50 | -0.26 | 0.19 | -2.17 | -2.51 |
| Profitability Margins | |||||
| Gross Profit Margin | 59.99% | 61.81% | 66.91% | 65.97% | 61.57% |
| EBIT Margin | 16.55% | 14.58% | 21.79% | 33.96% | 28.05% |
| EBITDA Margin | 23.80% | 23.00% | 28.49% | 38.42% | 32.00% |
| Operating Profit Margin | 16.55% | 9.46% | 19.30% | 28.09% | 24.63% |
| Pretax Profit Margin | 2.50% | 13.61% | 21.20% | 33.84% | 27.71% |
| Net Profit Margin | 0.52% | 11.21% | 16.54% | 26.48% | 25.80% |
| Continuous Operations Profit Margin | -0.45% | 11.31% | 17.58% | 27.38% | 27.12% |
| Net Income Per EBT | 20.63% | 82.37% | 77.98% | 78.25% | 93.11% |
| EBT Per EBIT | 15.13% | 143.94% | 109.87% | 120.46% | 112.50% |
| Return on Assets (ROA) | 0.21% | 3.81% | 6.15% | 11.75% | 11.03% |
| Return on Equity (ROE) | 0.28% | 5.05% | 8.74% | 14.64% | 12.57% |
| Return on Capital Employed (ROCE) | 7.33% | 3.49% | 8.21% | 14.86% | 11.72% |
| Return on Invested Capital (ROIC) | -1.29% | 2.87% | 6.72% | 11.84% | 11.35% |
| Return on Tangible Assets | 0.22% | 4.11% | 6.63% | 11.77% | 11.06% |
| Earnings Yield | 0.10% | 1.93% | 2.85% | 6.29% | 6.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.69 | 5.43 | 4.56 | 7.33 | 4.71 |
| Payables Turnover | 18.25 | 12.57 | 2.53 | 2.15 | 3.46 |
| Inventory Turnover | 0.80 | 0.50 | 0.47 | 0.66 | 0.89 |
| Fixed Asset Turnover | 0.98 | 0.82 | 0.90 | 1.63 | 1.36 |
| Asset Turnover | 0.41 | 0.34 | 0.37 | 0.44 | 0.43 |
| Working Capital Turnover Ratio | 0.91 | 0.85 | 0.89 | 0.87 | 0.96 |
| Cash Conversion Cycle | 466.03 | 770.13 | 714.17 | 436.04 | 381.51 |
| Days of Sales Outstanding | 31.21 | 67.17 | 80.06 | 49.79 | 77.49 |
| Days of Inventory Outstanding | 454.81 | 732.00 | 778.44 | 555.92 | 409.54 |
| Days of Payables Outstanding | 20.00 | 29.04 | 144.33 | 169.67 | 105.51 |
| Operating Cycle | 486.02 | 799.17 | 858.50 | 605.71 | 487.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.83 | 1.03 | -0.42 | 2.31 | 1.29 |
| Free Cash Flow Per Share | 2.75 | 0.81 | -4.20 | 2.08 | 0.98 |
| Dividend Paid and CapEx Coverage Ratio | 7.72 | 2.56 | -0.09 | 3.89 | 4.22 |
| Capital Expenditure Coverage Ratio | 35.13 | 4.58 | -0.11 | 10.10 | 4.22 |
| Operating Cash Flow Coverage Ratio | 1.04 | 0.36 | -0.14 | 4.84 | 5.53 |
| Operating Cash Flow to Sales Ratio | 0.38 | 0.15 | -0.06 | 0.30 | 0.18 |
| Free Cash Flow Yield | 6.92% | 2.06% | -9.57% | 6.42% | 3.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1078.59 | 51.46 | 35.11 | 15.96 | 18.66 |
| Price-to-Sales (P/S) Ratio | 5.31 | 5.80 | 5.81 | 4.21 | 4.25 |
| Price-to-Book (P/B) Ratio | 2.84 | 2.62 | 3.07 | 2.33 | 2.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.45 | 48.48 | -10.45 | 15.56 | 30.79 |
| Price-to-Operating Cash Flow Ratio | 14.04 | 37.89 | -103.98 | 14.02 | 23.50 |
| Price-to-Earnings Growth (PEG) Ratio | -11.34 | -1.31 | -0.91 | 0.63 | 0.82 |
| Enterprise Value Multiple | 20.82 | 24.98 | 20.57 | 8.79 | 10.77 |
| Enterprise Value | 1.17B | 1.16B | 1.34B | 781.45M | 617.74M |
| EV to EBITDA | 20.82 | 24.98 | 20.57 | 8.79 | 10.77 |
| EV to Sales | 4.96 | 5.75 | 5.86 | 3.38 | 3.45 |
| EV to Free Cash Flow | 13.48 | 47.99 | -10.55 | 12.48 | 24.97 |
| EV to Operating Cash Flow | 13.10 | 37.50 | -104.97 | 11.25 | 19.05 |
| Tangible Book Value Per Share | 13.93 | 13.92 | 13.20 | 14.17 | 14.82 |
| Shareholders’ Equity Per Share | 14.02 | 14.95 | 14.30 | 13.91 | 14.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 1.18 | 0.17 | 0.17 | 0.19 | 0.02 |
| Revenue Per Share | 7.49 | 6.74 | 7.56 | 7.69 | 7.11 |
| Net Income Per Share | 0.04 | 0.76 | 1.25 | 2.04 | 1.84 |
| Tax Burden | 0.21 | 0.82 | 0.78 | 0.78 | 0.93 |
| Interest Burden | 0.15 | 0.93 | 0.97 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.13 | 0.17 | 0.18 | 0.15 | 0.15 |
| SG&A to Revenue | 0.30 | 0.35 | 0.30 | 0.23 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 73.24 | 1.13 | -0.34 | 0.89 | 0.65 |
Currency in TWD
